Evidence map›Paper›PMID 41776100›Full record

ArticleNature immunology2026

Exclusion of Notch from the contact site during efferocytosis restricts anticancer immunity.

Zhenrui Li, Beisi Xu, Piyush Sharma, Cliff Guy, Emilio Boada-Romero, Katherine Verbist, Ao Guo, Luigi Mari, Suresh Poudel, Mao Yang and 1 more

Abstract read
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhenrui LiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA. Zhenrui.Li@stjude.org.ORCID http://orcid.org/0000-0001-7172-7643
Beisi XuCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-0099-858X
Piyush SharmaDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-1185-9534
Cliff GuyDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Emilio Boada-RomeroDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-2482-076X
Katherine VerbistDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ao GuoDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-2597-7558
Luigi MariDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-2903-7689
Suresh PoudelDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Mao YangDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA. Douglas.Green@stjude.org.ORCID http://orcid.org/0000-0002-7332-1417

Funding

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA231620
6 · The paper itself

Abstract

The clearance of dying cells by phagocytes (efferocytosis) is important for maintenance of tissue homeostasis and the active repression of inflammatory responses but can promote an immunosuppressive tumor microenvironment. Here we show that Notch signaling is suppressed actively during efferocytosis and that activation of this pathway by ectopic expression of the Notch intracellular domain in myeloid cells improves anticancer immunity in mice. Contact with dead cells or IgG-coated surfaces induces the activation of an integrin barrier that excludes Notch from the contact site to prevent it signaling. The formation of this active integrin barrier requires the Rubicon-VPS34 complex, which recruits phospholipase D (PLD) to regulate integrin activation. Ablation of Rubicon in the host or inhibition of PLD increases Notch activation during efferocytosis and improves anticancer immunity in a manner dependent on Notch signaling. These findings identify a regulatory mechanism that restricts Notch signaling during efferocytosis.

Indexed as

EfferocytosisNeoplasmsPhagocytesReceptors, NotchAnimalsHumansIntegrinsIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMice, KnockoutPhagocytosisPhospholipase DSignal TransductionTumor MicroenvironmentIntegrinsIntracellular Signaling Peptides and ProteinsPhospholipase DReceptors, Notch

Identifiers

PMID41776100
PMCPMC13043306

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.